$104.18
-3.25-3.03%
Last update: 1:07 PM
15 minutes delayed
Comments
Loading...
Itron
ITRINASDAQ
want to know what
the Bulls & Bears Say?
Itron (NASDAQ:ITRI) Stock, Analyst Ratings, Price Targets, Forecasts
Itron Inc has a consensus price target of $91.76 based on the ratings of 18 analysts. The high is $130 issued by Guggenheim on July 11, 2024. The low is $43 issued by Wells Fargo on March 1, 2022. The 3 most-recent analyst ratings were released by Oppenheimer, JP Morgan, and Roth MKM on July 17, 2024, July 16, 2024, and July 16, 2024, respectively. With an average price target of $115.33 between Oppenheimer, JP Morgan, and Roth MKM, there's an implied 10.71% upside for Itron Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
JP Morgan
Roth MKM
Guggenheim
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for Itron
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/17/2024 | Buy Now | 7.51% | Oppenheimer | Noah Kaye | $110 → $112 | Maintains | Outperform | Get Alert |
| 07/16/2024 | Buy Now | 7.51% | JP Morgan | Mark Strouse | $104 → $112 | Maintains | Neutral | Get Alert |
| 07/16/2024 | Buy Now | 17.11% | Roth MKM | Chip Moore | $112 → $122 | Maintains | Buy | Get Alert |
| 07/11/2024 | Buy Now | 24.78% | Guggenheim | Joseph Osha | → $130 | Upgrade | Neutral → Buy | Get Alert |
| 06/20/2024 | Buy Now | 15.19% | Canaccord Genuity | Austin Moeller | $115 → $120 | Maintains | Buy | Get Alert |
| 05/21/2024 | Buy Now | 4.63% | Piper Sandler | Kashy Harrison | $109 → $109 | Downgrade | Overweight → Neutral | Get Alert |
| 05/06/2024 | Buy Now | 5.59% | Stephens & Co. | Tommy Moll | $85 → $110 | Maintains | Equal-Weight | Get Alert |
| 05/03/2024 | Buy Now | 10.39% | Canaccord Genuity | Austin Moeller | $105 → $115 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 10.39% | TD Cowen | Jeffrey Osborne | $110 → $115 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 7.51% | Roth MKM | Chip Moore | $102 → $112 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 4.63% | Piper Sandler | Kashy Harrison | $103 → $109 | Reiterates | Overweight → Overweight | Get Alert |
| 05/03/2024 | Buy Now | 5.59% | Oppenheimer | Noah Kaye | $100 → $110 | Maintains | Outperform | Get Alert |
| 04/23/2024 | Buy Now | -2.09% | Roth MKM | Chip Moore | → $102 | Maintains | Buy | Get Alert |
| 04/11/2024 | Buy Now | -1.13% | Piper Sandler | Kashy Harrison | $105 → $103 | Maintains | Overweight | Get Alert |
| 03/13/2024 | Buy Now | 5.59% | TD Cowen | Jeffrey Osborne | $107 → $110 | Maintains | Outperform | Get Alert |
| 03/13/2024 | Buy Now | 10.39% | Baird | Ben Kallo | $108 → $115 | Maintains | Outperform | Get Alert |
| 03/13/2024 | Buy Now | -11.69% | JP Morgan | Mark Strouse | $77 → $92 | Maintains | Neutral | Get Alert |
| 02/27/2024 | Buy Now | 0.79% | Piper Sandler | Kashy Harrison | $91 → $105 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | 3.67% | Baird | Ben Kallo | $68 → $108 | Upgrade | Neutral → Outperform | Get Alert |
| 01/19/2024 | Buy Now | -22.25% | Oppenheimer | Noah Kaye | → $81 | Upgrade | Perform → Outperform | Get Alert |
| 01/04/2024 | Buy Now | — | Raymond James | Pavel Molchanov | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/19/2023 | Buy Now | -12.65% | Piper Sandler | Kashy Harrison | $72 → $91 | Upgrade | Neutral → Overweight | Get Alert |
| 12/12/2023 | Buy Now | -34.73% | JP Morgan | Paul Coster | → $68 | Upgrade | Underweight → Neutral | Get Alert |
| 12/05/2023 | Buy Now | -21.29% | Roth MKM | Chip Moore | → $82 | Initiates | → Buy | Get Alert |
| 12/01/2023 | Buy Now | -34.73% | Canaccord Genuity | Austin Moeller | → $68 | Initiates | → Hold | Get Alert |
| 11/03/2023 | Buy Now | -30.89% | Piper Sandler | Kashy Harrison | $71 → $72 | Maintains | Neutral | Get Alert |
| 10/19/2023 | Buy Now | -37.61% | JP Morgan | Paul Coster | $72 → $65 | Maintains | Underweight | Get Alert |
| 10/06/2023 | Buy Now | -31.85% | Piper Sandler | Kashy Harrison | $63 → $71 | Maintains | Neutral | Get Alert |
| 09/22/2023 | Buy Now | -23.21% | Seaport Global | Scott Graham | → $80 | Initiates | → Buy | Get Alert |
| 09/11/2023 | Buy Now | — | Guggenheim | Joseph Osha | — | Initiates | → Neutral | Get Alert |
| 08/18/2023 | Buy Now | -21.29% | Argus Research | John Eade | → $82 | Upgrade | Hold → Buy | Get Alert |
| 08/04/2023 | Buy Now | -8.81% | TD Cowen | Jeffrey Osborne | $85 → $95 | Maintains | Outperform | Get Alert |
| 08/04/2023 | Buy Now | -28.01% | Baird | Ben Kallo | $63 → $75 | Maintains | Neutral | Get Alert |
| 07/12/2023 | Buy Now | — | Raymond James | Pavel Molchanov | — | Downgrade | Strong Buy → Outperform | Get Alert |
| 05/08/2023 | Buy Now | -39.53% | Piper Sandler | Kashy Harrison | $58 → $63 | Maintains | Neutral | Get Alert |
| 05/05/2023 | Buy Now | -32.81% | EF Hutton | Chip Moore | $60 → $70 | Maintains | Buy | Get Alert |
| 05/05/2023 | Buy Now | -39.53% | Baird | Ben Kallo | $52 → $63 | Maintains | Neutral | Get Alert |
| 05/05/2023 | Buy Now | -32.81% | Raymond James | Pavel Molchanov | $60 → $70 | Maintains | Strong Buy | Get Alert |
| 03/03/2023 | Buy Now | -52.01% | JP Morgan | Paul Coster | $53 → $50 | Downgrade | Neutral → Underweight | Get Alert |
| 02/28/2023 | Buy Now | -56.81% | Stephens & Co. | Tommy Moll | → $45 | Reiterates | → Equal-Weight | Get Alert |
| 02/28/2023 | Buy Now | -44.33% | Piper Sandler | Kashy Harrison | $48 → $58 | Maintains | Neutral | Get Alert |
| 02/28/2023 | Buy Now | -50.09% | Baird | Ben Kallo | $40 → $52 | Maintains | Neutral | Get Alert |
| 02/28/2023 | Buy Now | -42.41% | EF Hutton | Chip Moore | → $60 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | Buy Now | -42.41% | Raymond James | Pavel Molchanov | $57 → $60 | Maintains | Strong Buy | Get Alert |
| 02/02/2023 | Buy Now | -30.89% | Cowen & Co. | Jeffrey Osborne | $55 → $72 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | -52.01% | Morgan Stanley | Connor Lynagh | $55 → $50 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | -42.41% | EF Hutton | Chip Moore | $72 → $60 | Maintains | Buy | Get Alert |
| 11/04/2022 | Buy Now | -45.29% | Raymond James | Pavel Molchanov | $68 → $57 | Maintains | Strong Buy | Get Alert |
| 10/20/2022 | Buy Now | -44.33% | JP Morgan | Mark Strouse | $65 → $58 | Maintains | Neutral | Get Alert |
| 08/08/2022 | Buy Now | — | JP Morgan | Paul Coster | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/05/2022 | Buy Now | -47.21% | Stephens & Co. | Tommy Moll | $65 → $55 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/20/2022 | Buy Now | -29.93% | JP Morgan | Mark Strouse | $71 → $73 | Maintains | Overweight | Get Alert |
| 07/19/2022 | Buy Now | -52.01% | Piper Sandler | Pearce Hammond | $51 → $50 | Maintains | Neutral | Get Alert |
| 07/12/2022 | Buy Now | -34.73% | Raymond James | Pavel Molchanov | $72 → $68 | Maintains | Strong Buy | Get Alert |
| 06/09/2022 | Buy Now | -47.21% | Morgan Stanley | Connor Lynagh | $60 → $55 | Maintains | Equal-Weight | Get Alert |
| 05/03/2022 | Buy Now | -19.37% | EF Hutton | Chip Moore | $92 → $84 | Maintains | Buy | Get Alert |
| 03/02/2022 | Buy Now | -37.61% | Stephens & Co. | Tommy Moll | $90 → $65 | Maintains | Overweight | Get Alert |
| 03/01/2022 | Buy Now | -11.69% | EF Hutton | Chip Moore | $102 → $92 | Maintains | Buy | Get Alert |
| 03/01/2022 | Buy Now | -42.41% | Morgan Stanley | Connor Lynagh | $75 → $60 | Maintains | Equal-Weight | Get Alert |
| 03/01/2022 | Buy Now | -58.73% | Wells Fargo | Michael Mcginn | $60 → $43 | Maintains | Equal-Weight | Get Alert |
| 01/10/2022 | Buy Now | -42.41% | Wells Fargo | Michael Mcginn | $75 → $60 | Maintains | Equal-Weight | Get Alert |
| 12/20/2021 | Buy Now | — | Argus Research | John Eade | — | Downgrade | Buy → Hold | Get Alert |
| 11/08/2021 | Buy Now | -19.37% | Piper Sandler | Pearce Hammond | — | Downgrade | Overweight → Neutral | Get Alert |
| 10/06/2021 | Buy Now | — | Oppenheimer | Noah Kaye | — | Downgrade | Outperform → Perform | Get Alert |
| 09/30/2021 | Buy Now | -28.01% | Wells Fargo | Michael Mcginn | — | Initiates | → Equal-Weight | Get Alert |
| 08/06/2021 | Buy Now | -28.01% | Baird | Ben Kallo | — | Downgrade | Outperform → Neutral | Get Alert |
| 08/06/2021 | Buy Now | -5.93% | Raymond James | Pavel Molchanov | — | Upgrade | Outperform → Strong Buy | Get Alert |
| 07/21/2021 | Buy Now | 15.19% | JP Morgan | Mark Strouse | — | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Itron (ITRI) stock?
The latest price target for Itron (NASDAQ:ITRI) was reported by Oppenheimer on July 17, 2024. The analyst firm set a price target for $112.00 expecting ITRI to rise to within 12 months (a possible 7.51% upside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Itron (ITRI)?
The latest analyst rating for Itron (NASDAQ:ITRI) was provided by Oppenheimer, and Itron maintained their outperform rating.
When was the last upgrade for Itron (ITRI)?
The last upgrade for Itron Inc happened on July 11, 2024 when Guggenheim raised their price target to $130. Guggenheim previously had a neutral for Itron Inc.
When was the last downgrade for Itron (ITRI)?
The last downgrade for Itron Inc happened on May 21, 2024 when Piper Sandler changed their price target from $109 to $109 for Itron Inc.
When is the next analyst rating going to be posted or updated for Itron (ITRI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Itron, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Itron was filed on July 17, 2024 so you should expect the next rating to be made available sometime around July 17, 2025.
Is the Analyst Rating Itron (ITRI) correct?
While ratings are subjective and will change, the latest Itron (ITRI) rating was a maintained with a price target of $110.00 to $112.00. The current price Itron (ITRI) is trading at is $104.18, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.